Drugs From Bausch, J&J And Amgen Top ICER's Unsupported Price Increase List

 
• By Jessica Merrill

Seven of the top 10 drugs with net price increases in 2021 that had a substantial effect on US spending did not have adequate new evidence to support any price increase, ICER determined.

Close-up Of White Increasing Staircase Arrow On Wooden Background
ICER released its report on unsupported drug price increases • Source: Shutterstock

More from Drug Pricing

More from Scrip